AP2755A - New azabicyclo[3.2.0]hept-3-yl compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents

New azabicyclo[3.2.0]hept-3-yl compounds, a process for their preparation and pharmaceutical compositions containing them

Info

Publication number: AP2755A
Authority: AP; ARIPO
Prior art keywords: hept; compounds; preparation; pharmaceutical compositions; compositions containing
Prior art date: 2009-12-09

Application number

AP2010005489A

Other languages

English (en)

Other versions

AP2010005489A0 (en

Inventor

Patrick Casara

Anne-Marie Chollet

Alain Dhainaut

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-12-09

Filing date

2010-12-01

Publication date

2013-09-30

2010-12-01 Application filed by Servier Lab filed Critical Servier Lab

2010-12-31 Publication of AP2010005489A0 publication Critical patent/AP2010005489A0/xx

2013-09-30 Application granted granted Critical

2013-09-30 Publication of AP2755A publication Critical patent/AP2755A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Child & Adolescent Psychology (AREA)
Anesthesiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)

AP2010005489A 2009-12-09 2010-12-01 New azabicyclo[3.2.0]hept-3-yl compounds, a process for their preparation and pharmaceutical compositions containing them AP2755A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0905957A FR2953514B1 (fr)	2009-12-09	2009-12-09	Nouveaux derives azabicyclo[3.2.0]hept-3-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number	Publication Date
AP2010005489A0 AP2010005489A0 (en)	2010-12-31
AP2755A true AP2755A (en)	2013-09-30

Family

ID=42133738

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2010005489A AP2755A (en)	2009-12-09	2010-12-01	New azabicyclo[3.2.0]hept-3-yl compounds, a process for their preparation and pharmaceutical compositions containing them

Country Status (44)

Country	Link
US (1)	US8008337B2 (pl)
EP (1)	EP2332910B1 (pl)
JP (1)	JP5511645B2 (pl)
KR (1)	KR101292705B1 (pl)
CN (1)	CN102127004B (pl)
AP (1)	AP2755A (pl)
AR (1)	AR079268A1 (pl)
AU (1)	AU2010246426B2 (pl)
BR (1)	BRPI1005270A2 (pl)
CA (1)	CA2724151C (pl)
CL (1)	CL2010001309A1 (pl)
CO (1)	CO6280059A1 (pl)
CR (1)	CR11811A (pl)
CU (1)	CU23993B1 (pl)
CY (1)	CY1113971T1 (pl)
DK (1)	DK2332910T3 (pl)
EA (1)	EA018971B1 (pl)
EC (1)	ECSP10010649A (pl)
ES (1)	ES2405206T3 (pl)
FR (1)	FR2953514B1 (pl)
GE (1)	GEP20135801B (pl)
HN (1)	HN2010002593A (pl)
HR (1)	HRP20130307T1 (pl)
IL (1)	IL209463A (pl)
JO (1)	JO2880B1 (pl)
MA (1)	MA32444B1 (pl)
ME (1)	ME01504B (pl)
MX (1)	MX2010013093A (pl)
MY (1)	MY150598A (pl)
NI (1)	NI201000206A (pl)
NZ (1)	NZ589763A (pl)
PE (1)	PE20110542A1 (pl)
PL (1)	PL2332910T3 (pl)
PT (1)	PT2332910E (pl)
RS (1)	RS52698B (pl)
SA (1)	SA110320007B1 (pl)
SG (1)	SG172543A1 (pl)
SI (1)	SI2332910T1 (pl)
SV (1)	SV2010003746A (pl)
TW (1)	TWI419875B (pl)
UA (1)	UA106721C2 (pl)
UY (1)	UY33046A (pl)
WO (1)	WO2011070250A1 (pl)
ZA (1)	ZA201008651B (pl)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005089747A1 (fr) *	2004-02-20	2005-09-29	Les Laboratoires Servier	Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI9300625B (sl) *	1993-12-02	2002-02-28	Basf Aktiengesellschaft	N-substituirani derivati azabicikloheptana, njihova priprava in uporaba
DE4341402A1 (de) *	1993-12-04	1995-06-08	Basf Ag	N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
DE4427647A1 (de) *	1994-08-04	1996-02-08	Basf Ag	N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung

2009
- 2009-12-09 FR FR0905957A patent/FR2953514B1/fr not_active Expired - Fee Related
2010
- 2010-11-19 MY MYPI2010005458 patent/MY150598A/en unknown
- 2010-11-21 IL IL209463A patent/IL209463A/en not_active IP Right Cessation
- 2010-11-22 JO JO2010408A patent/JO2880B1/en active
- 2010-11-22 UY UY0001033046A patent/UY33046A/es unknown
- 2010-11-23 SG SG2010085959A patent/SG172543A1/en unknown
- 2010-11-24 CR CR11811A patent/CR11811A/es not_active Application Discontinuation
- 2010-11-25 AU AU2010246426A patent/AU2010246426B2/en not_active Ceased
- 2010-11-25 PE PE2010001083A patent/PE20110542A1/es not_active Application Discontinuation
- 2010-11-26 CL CL2010001309A patent/CL2010001309A1/es unknown
- 2010-11-26 TW TW099141093A patent/TWI419875B/zh not_active IP Right Cessation
- 2010-11-29 CN CN2010105733405A patent/CN102127004B/zh not_active Expired - Fee Related
- 2010-11-29 CO CO10150441A patent/CO6280059A1/es active IP Right Grant
- 2010-11-30 MX MX2010013093A patent/MX2010013093A/es active IP Right Grant
- 2010-12-01 EC EC2010010649A patent/ECSP10010649A/es unknown
- 2010-12-01 AP AP2010005489A patent/AP2755A/xx active
- 2010-12-01 ZA ZA2010/08651A patent/ZA201008651B/en unknown
- 2010-12-01 MA MA33380A patent/MA32444B1/fr unknown
- 2010-12-02 SV SV2010003746A patent/SV2010003746A/es unknown
- 2010-12-02 NI NI201000206A patent/NI201000206A/es unknown
- 2010-12-02 CU CU2010000236A patent/CU23993B1/es not_active IP Right Cessation
- 2010-12-03 CA CA2724151A patent/CA2724151C/fr not_active Expired - Fee Related
- 2010-12-06 UA UAA201014568A patent/UA106721C2/uk unknown
- 2010-12-06 AR ARP100104487A patent/AR079268A1/es unknown
- 2010-12-07 NZ NZ589763A patent/NZ589763A/en not_active IP Right Cessation
- 2010-12-07 EA EA201001755A patent/EA018971B1/ru not_active IP Right Cessation
- 2010-12-07 SA SA110320007A patent/SA110320007B1/ar unknown
- 2010-12-07 KR KR1020100124116A patent/KR101292705B1/ko not_active IP Right Cessation
- 2010-12-07 GE GEAP201012026A patent/GEP20135801B/en unknown
- 2010-12-07 US US12/928,237 patent/US8008337B2/en not_active Expired - Fee Related
- 2010-12-08 RS RS20130092A patent/RS52698B/en unknown
- 2010-12-08 HN HN2010002593A patent/HN2010002593A/es unknown
- 2010-12-08 ME MEP-2013-42A patent/ME01504B/me unknown
- 2010-12-08 BR BRPI1005270-4A patent/BRPI1005270A2/pt not_active IP Right Cessation
- 2010-12-08 DK DK10290642.7T patent/DK2332910T3/da active
- 2010-12-08 PT PT102906427T patent/PT2332910E/pt unknown
- 2010-12-08 WO PCT/FR2010/000820 patent/WO2011070250A1/fr active Application Filing
- 2010-12-08 EP EP10290642A patent/EP2332910B1/fr active Active
- 2010-12-08 PL PL10290642T patent/PL2332910T3/pl unknown
- 2010-12-08 ES ES10290642T patent/ES2405206T3/es active Active
- 2010-12-08 SI SI201030183T patent/SI2332910T1/sl unknown
- 2010-12-09 JP JP2010274280A patent/JP5511645B2/ja not_active Expired - Fee Related
2013
- 2013-04-04 HR HRP20130307AT patent/HRP20130307T1/hr unknown
- 2013-04-29 CY CY20131100354T patent/CY1113971T1/el unknown

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005089747A1 (fr) *	2004-02-20	2005-09-29	Les Laboratoires Servier	Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number	Publication date
TW201200498A (en)	2012-01-01
CO6280059A1 (es)	2011-05-20
MX2010013093A (es)	2011-06-14
AU2010246426A1 (en)	2011-06-23
SA110320007B1 (ar)	2013-10-03
SV2010003746A (es)	2011-03-15
CY1113971T1 (el)	2016-07-27
NZ589763A (en)	2012-05-25
HN2010002593A (es)	2013-03-18
FR2953514B1 (fr)	2011-12-23
MY150598A (en)	2014-01-30
ES2405206T3 (es)	2013-05-30
JP5511645B2 (ja)	2014-06-04
CN102127004A (zh)	2011-07-20
IL209463A0 (en)	2011-02-28
SG172543A1 (en)	2011-07-28
AP2010005489A0 (en)	2010-12-31
GEP20135801B (en)	2013-04-10
CU23993B1 (es)	2014-04-24
CU20100236A7 (es)	2011-11-15
HRP20130307T1 (hr)	2013-04-30
EP2332910A1 (fr)	2011-06-15
PT2332910E (pt)	2013-02-26
CL2010001309A1 (es)	2012-01-13
EA201001755A1 (ru)	2011-10-31
PL2332910T3 (pl)	2013-06-28
EP2332910B1 (fr)	2013-01-30
KR101292705B1 (ko)	2013-08-02
JP2011121945A (ja)	2011-06-23
BRPI1005270A2 (pt)	2013-04-30
ME01504B (me)	2014-04-20
FR2953514A1 (fr)	2011-06-10
PE20110542A1 (es)	2011-08-18
UA106721C2 (uk)	2014-10-10
JO2880B1 (en)	2015-03-15
SI2332910T1 (sl)	2013-05-31
US8008337B2 (en)	2011-08-30
EA018971B1 (ru)	2013-12-30
RS52698B (en)	2013-08-30
US20110136886A1 (en)	2011-06-09
MA32444B1 (fr)	2011-07-03
DK2332910T3 (da)	2013-05-13
CR11811A (es)	2011-02-04
ECSP10010649A (es)	2011-07-29
UY33046A (es)	2011-05-31
IL209463A (en)	2014-06-30
TWI419875B (zh)	2013-12-21
AR079268A1 (es)	2012-01-04
CN102127004B (zh)	2013-10-23
AU2010246426B2 (en)	2013-06-27
CA2724151A1 (fr)	2011-06-09
KR20110065384A (ko)	2011-06-15
CA2724151C (fr)	2013-03-26
ZA201008651B (en)	2011-10-26
WO2011070250A1 (fr)	2011-06-16
NI201000206A (es)	2014-01-07

Publication	Publication Date	Title
ZA200704957B (en)	2008-08-27	Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
AP2384A (en)	2012-03-21	1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them.
AP3024A (en)	2014-11-30	New Diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them
AP2011005935A0 (en)	2011-10-31	New Benzothiadiazepine compounds, a process for their preparation and pharmaceutical compositions comprising them.
IL200128A0 (en)	2010-04-15	New tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them
HK1155742A1 (en)	2012-05-25	Dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
HK1096386A1 (en)	2007-06-01	Indanyl-piperazine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200603810B (en)	2007-08-29	Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
HK1126190A1 (en)	2009-08-28	Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
HK1096097A1 (en)	2007-05-25	Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
HK1111403A1 (en)	2008-08-08	New naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
ZA201000025B (en)	2011-04-28	New naphthalene compounds,a process for their preparation and pharmaceutical compositions containing them
AP2009004891A0 (en)	2009-06-30	New azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them
ZA201000024B (en)	2011-04-28	New naphthalene compounds,a process for their preparation and pharmaceutical compositions containing them
ZA201203943B (en)	2013-08-28	New azabicyclo[3.1.0]hex-2-yl compounds,a process for their preparation and pharmaceutical compositions containing them
AP2755A (en)	2013-09-30	New azabicyclo[3.2.0]hept-3-yl compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200704956B (en)	2008-08-27	Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
AP2010005304A0 (en)	2010-06-30	New 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200800833B (en)	2009-04-29	New 1H-indole-pyridinecarboxamide and 1H-indolepiperidinecarboxamide compounds, a process for their preparation and pharmaceutical compositions containing them
AP2010005328A0 (en)	2010-08-31	New piperidine compounds, a process for their preparation and pharmaceutical compositions containingthem.
AP2010005327A0 (en)	2010-08-31	New chromene compounds, a process for their preparation and pharmaceutical compositions containing them.